about
Systems biology of the microvasculatureSite-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational ModelMolecular mechanism matters: Benefits of mechanistic computational models for drug development.A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.Further Support for ECM Control of Receptor Trafficking and Signaling.Systems Pharmacology of VEGF165b in Peripheral Artery Disease.Arterialized collateral capillaries progress from non-reactive to capable of increasing perfusion in an ischemic tree.A computational analysis of pro-angiogenic therapies for peripheral artery disease.Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCELEffects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trialPrediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL
P50
Q26850123-44EC70CF-CFF8-4345-A674-F1245B1204A7Q35661415-EEDC9BFD-A90B-478B-9475-C0C625ACC48DQ36052870-3CB40F0E-5710-49F3-8DCC-36C3679E5D7BQ36314931-506EB21D-F6AA-4F4C-8367-ED19E21A465DQ43468852-9BBDBE53-B94A-4386-A380-BB3401FB926AQ45074473-83FFE158-E924-4C62-B4E2-EC1D63CED495Q47212976-090AC127-10A9-4590-9ECA-1FA491313786Q50071368-88186AB4-4A81-4CF7-8CC8-CECFEC16318CQ90315969-85224D67-C1B4-48F6-ACAE-68C3B74DF0E9Q90880186-274DC36F-C9BE-41E3-8B27-F8F66776D07BQ92486873-3C8EBD08-9E07-4487-9DA6-9AED3A077828
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-8558-9341
@en
name
Lindsay E Clegg
@ast
Lindsay E Clegg
@en
Lindsay E Clegg
@nl
type
label
Lindsay E Clegg
@ast
Lindsay E Clegg
@en
Lindsay E Clegg
@nl
prefLabel
Lindsay E Clegg
@ast
Lindsay E Clegg
@en
Lindsay E Clegg
@nl
P106
P31
P496
0000-0001-8558-9341